2 participants
Cabazitaxel and Prednisone in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2021-01-25
- Start Date:
- 2017-12-20
- Completion:
- 2019-06-04
Conditions
- Hormone-Resistant Prostate Cancer
- Stage IV Prostate Adenocarcinoma
Interventions
- DRUG